FLORHAM PARK, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused.
Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
FLORHAM PARK, N.J., Jan. 30, 2024 Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the.
FLORHAM PARK, N.J., Jan. 25, 2024 Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the.
Iopofosine I 131 Active in Treating Malignancies in the Brain; Confirmed Response in CNS Lymphoma Provides Additional Validation for Continued Development.